ENSG00000160957 |
RECQL4 |
colon adenocarcinoma |
frameshift_variant |
2.576% (33/1281) |
2 entries |
ENSG00000160957 |
RECQL4 |
colon adenocarcinoma |
conservative_inframe_deletion |
2.576% (33/1281) |
1 entry |
ENSG00000160957 |
RECQL4 |
colon adenocarcinoma |
stop_gained |
2.576% (33/1281) |
2 entries |
ENSG00000160957 |
RECQL4 |
colorectal adenocarcinoma |
missense_variant |
4.243% (53/1249) |
3 entries |
ENSG00000160957 |
RECQL4 |
colon adenocarcinoma |
sequence_alteration |
2.576% (33/1281) |
4 entries |
ENSG00000160957 |
RECQL4 |
colorectal adenocarcinoma |
sequence_alteration |
4.243% (53/1249) |
2 entries |
ENSG00000160957 |
RECQL4 |
colon adenocarcinoma |
missense_variant |
2.576% (33/1281) |
4 entries |
ENSG00000160957 |
RECQL4 |
pancreatic ductal adenocarcinoma |
missense_variant |
0.2973% (5/1682) |
1 entry |
ENSG00000160957 |
RECQL4 |
esophageal squamous cell carcinoma |
missense_variant |
1.312% (9/686) |
4 entries |
ENSG00000160957 |
RECQL4 |
central nervous system primitive neuroectodermal neoplasm |
sequence_alteration |
0.6696% (3/448) |
1 entry |
ENSG00000160957 |
RECQL4 |
skin melanoma |
sequence_alteration |
1.381% (16/1159) |
1 entry |
ENSG00000160957 |
RECQL4 |
Endometrial Endometrioid Adenocarcinoma |
missense_variant |
1.703% (11/646) |
1 entry |
ENSG00000160957 |
RECQL4 |
diffuse large B-cell lymphoma |
missense_variant |
0.5405% (2/370) |
1 entry |
ENSG00000160957 |
RECQL4 |
small cell lung carcinoma |
frameshift_variant |
1.121% (5/446) |
1 entry |
ENSG00000160957 |
RECQL4 |
esophageal adenocarcinoma |
sequence_alteration |
0.9174% (5/545) |
1 entry |
ENSG00000160957 |
RECQL4 |
gastric adenocarcinoma |
missense_variant |
2.026% (17/839) |
2 entries |
ENSG00000160957 |
RECQL4 |
esophageal adenocarcinoma |
missense_variant |
0.9174% (5/545) |
1 entry |
ENSG00000160957 |
RECQL4 |
female breast carcinoma |
missense_variant |
0.7673% (3/391) |
2 entries |
ENSG00000160957 |
RECQL4 |
clear cell renal carcinoma |
missense_variant |
0.2527% (4/1583) |
2 entries |
ENSG00000160957 |
RECQL4 |
Mixed Lobular and Ductal Breast Carcinoma |
missense_variant |
5.0% (3/60) |
1 entry |
ENSG00000160957 |
RECQL4 |
cecum adenocarcinoma |
sequence_alteration |
3.717% (10/269) |
1 entry |
ENSG00000160957 |
RECQL4 |
bladder transitional cell carcinoma |
stop_gained |
2.466% (11/446) |
1 entry |
ENSG00000160957 |
RECQL4 |
esophageal squamous cell carcinoma |
sequence_alteration |
1.312% (9/686) |
2 entries |
ENSG00000160957 |
RECQL4 |
bile duct adenocarcinoma |
missense_variant |
1.299% (5/385) |
2 entries |
ENSG00000160957 |
RECQL4 |
head and neck squamous cell carcinoma |
missense_variant |
0.534% (4/749) |
2 entries |
ENSG00000160957 |
RECQL4 |
breast ductal adenocarcinoma |
sequence_alteration |
0.8217% (13/1582) |
1 entry |
ENSG00000160957 |
RECQL4 |
gastric intestinal type adenocarcinoma |
sequence_alteration |
5.882% (5/85) |
1 entry |
ENSG00000160957 |
RECQL4 |
lobular breast carcinoma |
sequence_alteration |
1.299% (3/231) |
1 entry |
ENSG00000160957 |
RECQL4 |
small cell lung carcinoma |
sequence_alteration |
1.121% (5/446) |
2 entries |
ENSG00000160957 |
RECQL4 |
melanoma |
missense_variant |
5.517% (8/145) |
3 entries |
ENSG00000160957 |
RECQL4 |
melanoma |
sequence_alteration |
5.517% (8/145) |
2 entries |
ENSG00000160957 |
RECQL4 |
skin melanoma |
missense_variant |
1.381% (16/1159) |
1 entry |
ENSG00000160957 |
RECQL4 |
brain glioblastoma |
sequence_alteration |
0.495% (6/1212) |
1 entry |
ENSG00000160957 |
RECQL4 |
non-small cell lung carcinoma |
sequence_alteration |
2.857% (3/105) |
1 entry |
ENSG00000160957 |
RECQL4 |
prostate carcinoma |
missense_variant |
1.446% (7/484) |
2 entries |
ENSG00000160957 |
RECQL4 |
non-small cell lung carcinoma |
missense_variant |
2.857% (3/105) |
1 entry |
ENSG00000160957 |
RECQL4 |
breast carcinoma |
missense_variant |
0.6106% (9/1474) |
2 entries |
ENSG00000160957 |
RECQL4 |
brain glioblastoma |
missense_variant |
0.495% (6/1212) |
1 entry |
ENSG00000160957 |
RECQL4 |
lung adenocarcinoma |
missense_variant |
1.125% (29/2578) |
3 entries |
ENSG00000160957 |
RECQL4 |
lung adenocarcinoma |
sequence_alteration |
1.125% (29/2578) |
2 entries |
ENSG00000160957 |
RECQL4 |
urothelial carcinoma |
missense_variant |
5.814% (5/86) |
1 entry |
ENSG00000160957 |
RECQL4 |
skin melanoma |
frameshift_variant |
1.381% (16/1159) |
1 entry |
ENSG00000160957 |
RECQL4 |
prostate adenocarcinoma |
sequence_alteration |
0.4188% (9/2149) |
2 entries |
ENSG00000160957 |
RECQL4 |
breast ductal adenocarcinoma |
missense_variant |
0.8217% (13/1582) |
1 entry |
ENSG00000160957 |
RECQL4 |
gastric intestinal type adenocarcinoma |
missense_variant |
5.882% (5/85) |
1 entry |
ENSG00000160957 |
RECQL4 |
ovarian serous adenocarcinoma |
missense_variant |
0.2407% (2/831) |
1 entry |
ENSG00000160957 |
RECQL4 |
bladder transitional cell carcinoma |
sequence_alteration |
2.466% (11/446) |
1 entry |
ENSG00000160957 |
RECQL4 |
squamous cell lung carcinoma |
missense_variant |
1.206% (12/995) |
2 entries |
ENSG00000160957 |
RECQL4 |
Merkel cell skin cancer |
missense_variant |
2.151% (2/93) |
1 entry |
ENSG00000160957 |
RECQL4 |
rectal adenocarcinoma |
missense_variant |
0.3663% (2/546) |
1 entry |
ENSG00000160957 |
RECQL4 |
oral squamous cell carcinoma |
sequence_alteration |
1.509% (4/265) |
3 entries |
ENSG00000160957 |
RECQL4 |
oral squamous cell carcinoma |
missense_variant |
1.509% (4/265) |
3 entries |
ENSG00000160957 |
RECQL4 |
small cell lung carcinoma |
missense_variant |
1.121% (5/446) |
2 entries |
ENSG00000160957 |
RECQL4 |
squamous cell lung carcinoma |
sequence_alteration |
1.206% (12/995) |
2 entries |
ENSG00000160957 |
RECQL4 |
lobular breast carcinoma |
missense_variant |
1.299% (3/231) |
1 entry |
ENSG00000160957 |
RECQL4 |
colorectal adenocarcinoma |
frameshift_variant |
4.243% (53/1249) |
1 entry |
ENSG00000160957 |
RECQL4 |
bladder transitional cell carcinoma |
missense_variant |
2.466% (11/446) |
1 entry |
ENSG00000160957 |
RECQL4 |
Endometrial Endometrioid Adenocarcinoma |
sequence_alteration |
1.703% (11/646) |
1 entry |
ENSG00000160957 |
RECQL4 |
cecum adenocarcinoma |
missense_variant |
3.717% (10/269) |
1 entry |
ENSG00000160957 |
RECQL4 |
prostate carcinoma |
sequence_alteration |
1.446% (7/484) |
2 entries |
ENSG00000160957 |
RECQL4 |
Pleural Epithelioid Mesothelioma |
missense_variant |
1.481% (2/135) |
1 entry |
ENSG00000160957 |
RECQL4 |
urothelial carcinoma |
sequence_alteration |
5.814% (5/86) |
1 entry |
ENSG00000160957 |
RECQL4 |
prostate adenocarcinoma |
missense_variant |
0.4188% (9/2149) |
1 entry |
ENSG00000160957 |
RECQL4 |
cecum adenocarcinoma |
stop_gained |
3.717% (10/269) |
1 entry |
ENSG00000160957 |
RECQL4 |
laryngeal squamous cell carcinoma |
missense_variant |
4.878% (2/41) |
2 entries |
ENSG00000160957 |
RECQL4 |
ovarian clear cell adenocarcinoma |
sequence_alteration |
3.03% (1/33) |
1 entry |
ENSG00000160957 |
RECQL4 |
rectal adenocarcinoma |
sequence_alteration |
0.3663% (2/546) |
1 entry |
ENSG00000160957 |
RECQL4 |
pancreatic ductal adenocarcinoma |
frameshift_variant |
0.2973% (5/1682) |
1 entry |
ENSG00000160957 |
RECQL4 |
Mixed Lobular and Ductal Breast Carcinoma |
sequence_alteration |
5.0% (3/60) |
1 entry |
ENSG00000160957 |
RECQL4 |
embryonal rhabdomyosarcoma |
sequence_alteration |
1.163% (1/86) |
1 entry |
ENSG00000160957 |
RECQL4 |
prostate carcinoma |
stop_gained |
1.446% (7/484) |
1 entry |
ENSG00000160957 |
RECQL4 |
oral squamous cell carcinoma |
frameshift_variant |
1.509% (4/265) |
1 entry |
ENSG00000160957 |
RECQL4 |
gastric intestinal type adenocarcinoma |
frameshift_variant |
5.882% (5/85) |
1 entry |
ENSG00000160957 |
RECQL4 |
osteosarcoma |
missense_variant |
1.316% (2/152) |
1 entry |
ENSG00000160957 |
RECQL4 |
ovarian clear cell adenocarcinoma |
missense_variant |
3.03% (1/33) |
1 entry |
ENSG00000160957 |
RECQL4 |
nasopharyngeal squamous cell carcinoma |
missense_variant |
0.5556% (1/180) |
1 entry |
ENSG00000160957 |
RECQL4 |
Endometrial Endometrioid Adenocarcinoma |
frameshift_variant |
1.703% (11/646) |
1 entry |
ENSG00000160957 |
RECQL4 |
Thyroid Gland Undifferentiated (Anaplastic) Carcinoma |
missense_variant |
1.01% (1/99) |
1 entry |
ENSG00000160957 |
RECQL4 |
Gastrointestinal stromal tumor |
sequence_alteration |
0.6757% (1/148) |
1 entry |
ENSG00000160957 |
RECQL4 |
gastric adenocarcinoma |
stop_gained |
2.026% (17/839) |
1 entry |
ENSG00000160957 |
RECQL4 |
ovarian serous adenocarcinoma |
sequence_alteration |
0.2407% (2/831) |
1 entry |
ENSG00000160957 |
RECQL4 |
Merkel cell skin cancer |
sequence_alteration |
2.151% (2/93) |
1 entry |
ENSG00000160957 |
RECQL4 |
Gallbladder Adenocarcinoma |
sequence_alteration |
1.227% (2/163) |
1 entry |
ENSG00000160957 |
RECQL4 |
anaplastic oligodendroglioma |
sequence_alteration |
1.176% (1/85) |
1 entry |
ENSG00000160957 |
RECQL4 |
Intimal Sarcoma |
sequence_alteration |
12.5% (1/8) |
1 entry |
ENSG00000160957 |
RECQL4 |
Pancreatic Acinar Cell Carcinoma |
frameshift_variant |
5.882% (2/34) |
1 entry |
ENSG00000160957 |
RECQL4 |
diffuse gastric adenocarcinoma |
sequence_alteration |
2.439% (2/82) |
1 entry |
ENSG00000160957 |
RECQL4 |
osteosarcoma |
sequence_alteration |
1.316% (2/152) |
1 entry |
ENSG00000160957 |
RECQL4 |
anaplastic oligodendroglioma |
missense_variant |
1.176% (1/85) |
1 entry |
ENSG00000160957 |
RECQL4 |
papillary renal cell carcinoma |
amino_acid_insertion |
0.2725% (1/367) |
1 entry |
ENSG00000160957 |
RECQL4 |
Gastrointestinal stromal tumor |
missense_variant |
0.6757% (1/148) |
1 entry |
ENSG00000160957 |
RECQL4 |
embryonal rhabdomyosarcoma |
missense_variant |
1.163% (1/86) |
1 entry |
ENSG00000160957 |
RECQL4 |
Pleural Epithelioid Mesothelioma |
sequence_alteration |
1.481% (2/135) |
1 entry |
ENSG00000160957 |
RECQL4 |
diffuse gastric adenocarcinoma |
missense_variant |
2.439% (2/82) |
1 entry |
ENSG00000160957 |
RECQL4 |
lung carcinoid tumor |
missense_variant |
3.704% (1/27) |
1 entry |
ENSG00000160957 |
RECQL4 |
endometrial carcinoma |
missense_variant |
4.167% (1/24) |
1 entry |
ENSG00000160957 |
RECQL4 |
lung adenocarcinoma |
frameshift_variant |
1.125% (29/2578) |
1 entry |
ENSG00000160957 |
RECQL4 |
Duodenal Adenocarcinoma |
missense_variant |
5.882% (1/17) |
1 entry |
ENSG00000160957 |
RECQL4 |
leiomyosarcoma |
sequence_alteration |
1.0% (1/100) |
1 entry |
ENSG00000160957 |
RECQL4 |
leiomyosarcoma |
missense_variant |
1.0% (1/100) |
1 entry |
ENSG00000160957 |
RECQL4 |
head and neck squamous cell carcinoma |
sequence_alteration |
0.534% (4/749) |
1 entry |
ENSG00000160957 |
RECQL4 |
squamous cell lung carcinoma |
conservative_inframe_deletion |
1.206% (12/995) |
1 entry |
ENSG00000160957 |
RECQL4 |
pancreatic ductal adenocarcinoma |
sequence_alteration |
0.2973% (5/1682) |
1 entry |
ENSG00000160957 |
RECQL4 |
Intimal Sarcoma |
missense_variant |
12.5% (1/8) |
1 entry |
ENSG00000160957 |
RECQL4 |
laryngeal squamous cell carcinoma |
sequence_alteration |
4.878% (2/41) |
1 entry |
ENSG00000160957 |
RECQL4 |
breast ductal adenocarcinoma |
conservative_inframe_deletion |
0.8217% (13/1582) |
1 entry |
ENSG00000160957 |
RECQL4 |
gastric adenocarcinoma |
frameshift_variant |
2.026% (17/839) |
1 entry |
ENSG00000160957 |
RECQL4 |
basal cell carcinoma |
frameshift_variant |
1.471% (1/68) |
1 entry |
ENSG00000160957 |
RECQL4 |
Pancreatic Acinar Cell Carcinoma |
sequence_alteration |
5.882% (2/34) |
1 entry |
ENSG00000160957 |
RECQL4 |
cecum adenocarcinoma |
conservative_inframe_deletion |
3.717% (10/269) |
1 entry |
ENSG00000160957 |
RECQL4 |
Gallbladder Adenocarcinoma |
missense_variant |
1.227% (2/163) |
1 entry |